Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001179110-20-002033

SVP & Chief Medical Officer sold 32,280 shares at an average $18.48 ($596,487)

  • SVP & Chief Medical Officer acquired 32,280 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Paolini John F. · SVP & Chief Medical Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2020-02-19 Exercise or conversion : show line 1 in the form +22,477 $3.80 $85,413 40,477 D
2020-02-19 Sale : show line 2 in the form −22,477 $18.27 $410,655 18,000 D
2020-02-20 Exercise or conversion : show line 3 in the form +9,803 $3.80 $37,251 27,803 D
2020-02-20 Sale : show line 4 in the form −8,687 $18.91 $164,271 19,116 D
2020-02-20 Sale : show line 5 in the form −1,116 $19.32 $21,561 18,000 D
Open-market sales · 32,280 sh · avg $18.48 · $596,487

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2020-02-19 Exercise or conversion : show line 6 in the form Share Option −22,477 76,345 D
2020-02-20 Exercise or conversion : show line 7 in the form Share Option −9,803 66,542 D
Loading xslF345X03/edgar.xml…